No CVD Issues Apparent Years After Aromatase Inhibitor Therapy No CVD Issues Apparent Years After Aromatase Inhibitor Therapy

The findings in breast cancer survivors are ' reassuring, ' given the benefit of aromatase inhibitors, the authors say. The study was published as a preprint and has not yet been peer reviewed.First Look
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Ob/Gyn & Women ' s Health News Source Type: news